<?xml version="1.0" encoding="UTF-8"?>
<p id="p0275">The potentially beneficial role of traditional Chinese medicine is described in the guidelines of the NHC, and some Chinese patent medicines (CPMs) have been used to treat COVID-19.
 <xref rid="bib10" ref-type="bibr">
  <sup>10</sup>
 </xref> However, the experience with most of these treatments is anecdotal. Gu et al. reviewed 93 Chinese medicine prescriptions and 157 forms of constituent medicines for COVID-19 treatment and found that they may be effective in reducing fever, mucous production, cough, and asthma symptoms.
 <xref rid="bib64" ref-type="bibr">
  <sup>64</sup>
 </xref> Yan et al. discovered that 10 antiviral components from CPMs can directly bind to both host cell target angiotensin-converting enzyme (ACE) 2 receptor and viral target main protease, suggesting their potential for COVID-19 treatment.
 <xref rid="bib65" ref-type="bibr">
  <sup>65</sup>
 </xref>
</p>
